Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

2 Top High-Growth Stocks to Buy Right Now

Published 2021-05-20, 08:00 a/m
2 Top High-Growth Stocks to Buy Right Now
CRH
-

Spin Master (TSX:TOY) and WELL Health Technologies (TSX:WELL) are two top high-growth stocks to buy right now. They reported solid results in their latest quarter, and strong growth is expected in the future.

Spin Master The toy and children entertainment company is one of the best high-growth stocks to buy right now. Spin Master reported strong first-quarter financial results on May 12 and said new initiatives would continue to drive growth.

Revenue increased by almost 40% compared to the same quarter last year. A strong performance from digital games contributed to the success of the quarter.

Indeed, the total revenue of Spin Master for Q1 2021 was US$316.6 million compared to revenue of US$227.3 million reported in Q1 2020. Gaming revenue digital products grew 394.2% to US$34.1 million, driven by the Toca Life World platform and a growing Sago Mini user base.

Meanwhile, the company reported a profit of US$3.2 million (US$0.03 per share) in Q1 2021 compared to a loss of US$26.7 million (US$0.26 per share) in Q1 2020.

On an adjusted basis, Spin Master earned US$0.08 per share for the first quarter compared to an adjusted loss of US$0.46 per share in the prior-year quarter.

Executives at Spin Master told analysts that digital games and a Paw Patrol movie slated for release in August will complement its other lines of business.

The company now expects total revenue for 2021 to grow in the double digits from 2020 compared to the mid- to high single-digit figures previously announced on March 3, 2021.

In addition, it expects its digital games business as well as its entertainment and licensing business to continue growing throughout the year and contribute to an overall increase in revenues.

WELL Health WELL Health is an omnichannel digital health company with a number of business segments.

The company experienced strong revenue growth in the first quarter of 2021.

Indeed, revenue for the first quarter of 2021 was $25.6 million — an increase of 150% from a revenue of $10.2 million in the first quarter of 2020. WELL Health’s strong first-quarter performance was driven by 345% growth in sales of its software and services year over year.

At the same time, adjusted EBITDA was $0.5 million for Q1 2021 compared to an adjusted EBITDA of loss $0.2 million for Q1 2020.

The company reported a net loss of $7.1 million (-$0.04 per share) in the first quarter compared to a loss of $2 million (-$0.02 per share) in the same quarter a year earlier.

The company has a very active mergers and acquisitions program.

WELL has completed its largest acquisition to date in CRH (LON:CRH) Medical, an American gastroenterology and anesthesia company.

WELL took a number of steps after the end of the quarter, including launching iPhone Health Records for patients to view their available medical records on their iPhones, acquiring Ottawa-based healthcare company ExecHealth, acquiring a 51% stake in Doctors Services Group billing service, obtaining a modified senior secured credit agreement for a total amount of up to US$300 million, and completing the acquisition of the enterprise-class EMR company IntraHealth.

The omnichannel digital health company ended the first quarter of 2021 with $83.3 million in cash and loans and other borrowings of $1.7 million.

The post 2 Top High-Growth Stocks to Buy Right Now appeared first on The Motley Fool Canada.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Spin Master.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.